Inventor · disambiguated record
Julie M. Skinner
Also filed as: SKINNER JULIE M · SKINNER JULIE MARIE
11 granted patents·12 pending applications·29 citations·filing 2009–2024
87Inventor score
Files withMERCK SHARP & DOHME LLC15MERCK SHARP & DOHME6ADES EDWIN W1GOVERNMENT OF THE US SECRETARY OF THE DEPT OF HEALTH AND HUMAN SERVICES CT S FOR DISEASE CONTROL AND1
Top patents by PatentIndex Score
23 records- 0195US11850278B2Compositions comprising Streptococcus pneumoniae polysaccharide-protein conjugates and methods of use thereofMERCK SHARP & DOHME LLC·Filed 2021·Granted Dec 26, 2023·3 cites·2 claims
- 0293US11116828B2Compositions comprising Streptococcus pneumoniae polysaccharide-protein conjugates and methods of use thereofMERCK SHARP & DOHME·Filed 2018·Granted Sep 14, 2021·7 cites·49 claims
- 0391US11491216B2Pneumococcal polysaccharides and their use in immunogenic polysaccharide-carrier protein conjugatesMERCK SHARP & DOHME·Filed 2018·Granted Nov 8, 2022·3 cites·30 claims
- 0486US11090374B2Enhancing immunogenicity of Streptococcus pneumoniae polysaccharide-protein conjugatesMERCK SHARP & DOHME·Filed 2018·Granted Aug 17, 2021·3 cites·14 claims
- 0585US12097250B2Compositions comprising Streptococcus pneumoniae polysaccharide-protein conjugates and methods of use thereofMERCK SHARP & DOHME LLC·Filed 2023·Granted Sep 24, 2024·0 cites·9 claims
- 0685US11642406B2Compositions comprising Streptococcus pneumoniae polysaccharide-protein conjugates and methods of use thereofMERCK SHARP & DOHME LLC·Filed 2019·Granted May 9, 2023·2 cites·9 claims
- 0783US12295998B2Enhancing immunogenicity of Streptococcus pneumoniae polysaccharide-protein conjugatesMERCK SHARP & DOHME LLC·Filed 2023·Granted May 13, 2025·0 cites·2 claims
- 0883US2024398925A1Compositions comprising streptococcus pneumoniae polysaccharide-protein conjugates and methods of use thereofMERCK SHARP & DOHME LLC·Filed 2024·Application pending·0 cites
- 0982US2023041441A1Pneumococcal polysaccharides and their use in immunogenic polysaccharide-carrier protein conjugatesMERCK SHARP & DOHME LLC·Filed 2022·Application pending·0 cites
- 1080US2023107713A1Pneumococcal polysaccharides and their use in immunogenic polysaccharide-carrier protein conjugatesMERCK SHARP & DOHME LLC·Filed 2022·Application pending·0 cites
- 1180US2023094548A1Pneumococcal polysaccharides and their use in immunogenic polysaccharide-carrier protein conjugatesMERCK SHARP & DOHME LLC·Filed 2022·Application pending·0 cites
- 1280US2023029424A1Pneumococcal polysaccharides and their use in immunogenic polysaccharide-carrier protein conjugatesMERCK SHARP & DOHME LLC·Filed 2022·Application pending·0 cites
- 1380US2023075760A1Pneumococcal polysaccharides and their use in immunogenic polysaccharide-carrier protein conjugatesMERCK SHARP & DOHME LLC·Filed 2022·Application pending·0 cites
- 1477US12016914B2Compositions comprising Streptococcus pneumoniae polysaccharide-protein conjugates and methods of use thereofMERCK SHARP & DOHME LLC·Filed 2023·Granted Jun 25, 2024·0 cites·11 claims
- 1577US9388394B2Vaccines against clostridium difficile comprising recombinant toxinsMERCK SHARP & DOHME·Filed 2013·Granted Jul 12, 2016·10 cites·7 claims
- 1677US2024382576A1Compositions comprising streptococcus pneumoniae polysaccharide-protein conjugates and methods of use thereofMERCK SHARP & DOHME LLC·Filed 2024·Application pending·0 cites
- 1770US2024408188A1Nanoemulsion adjuvant compositions for human papillomavirus vaccinesMERCK SHARP & DOHME LLC·Filed 2024·Application pending·0 cites
- 1869US9101582B2Use of a pneumococcal P4 peptide for enhancing opsonophagocytosis in response to a pathogenGOVERNMENT OF THE US SECRETARY OF THE DEPT OF HEALTH AND HUMAN SERVICES CT S FOR DISEASE CONTROL AND·Filed 2013·Granted Aug 11, 2015·1 cites·4 claims
- 1969US8431134B2Use of a pneumococcal P4 peptide for enhancing opsonophagocytosis in response to a pathogenADES EDWIN W·Filed 2009·Granted Apr 30, 2013·0 cites·6 claims
- 2069US2021330777A1Enhancing immunogenicity of streptococcus pneumoniae polysaccharide-protein conjugatesMERCK SHARP & DOHME·Filed 2021·Application pending·0 cites
- 2158US2024108710A1Nanoemulsion adjuvant composition for pneumococcal conjugate vaccinesMERCK SHARP & DOHME LLC·Filed 2022·Application pending·0 cites
- 2257US2024123047A1Lipid nanoparticle adjuvant composition for pneumococcal conjugate vaccinesMERCK SHARP & DOHME LLC·Filed 2022·Application pending·0 cites
- 2347US2022218812A1Methods of treating patients with an immunogenic composition that protects against s. pneumoniae serotype 29MERCK SHARP & DOHME·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Julie M. Skinner files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →